The World Organisation for Animal Health (OIE) has published its 5th report on Antimicrobial Agents intended for use in animals where 160 countries (156 members, one non-contiguous territory and three non-OIE members) have contributed data. OIE has been engaged in combating antimicrobial resistance through a One Health approach. Globally very little information is available on resistance patterns in animal pathogens or in animal commensal bacterial. OIE recognises that surveillance of antimicrobial resistance in animal microorganisms is an important to assess the level and evolution of AMR in animals and later to provide a better understanding of the AM use and AMR epidemiology.
The CGIAR Antimicrobial Resistance Hub, led by the International Livestock Research Institute (ILRI), applies a One Health approach to support the efforts of low- and middle-income countries (LMICs) in controlling agriculture-associated AMR risks, through promoting and facilitating transdisciplinary partnerships.
The recently adopted CGIAR AMR strategy recognizes the need for evidence on links between agriculture (crops, livestock and aquaculture) and public health outcomes. Based on evidence generated, the hub develops solutions that are locally relevant and applicable, while being adaptable to other contexts.
We conduct context-driven and systems-oriented research that combines social and biological sciences. With AMR research in agriculture and aquaculture and understanding linkages to public health outcomes, we can reap solutions emerging from our transdisciplinary approach.
We aim to reduce and refine AMU in agriculture and aquaculture and its impact on the environment, and to facilitate evidence-based communication around agriculture-associated AMR. This will help to mitigate AMR risks for people and contributes to improving the sustainability of global food and health systems.
The implementation framework of our strategy is organized into five pillars.
Judiciously addressing antimicrobial resistance is especially important in low- and middle-income countries, where poverty exacerbates cycles of inequity
Tackling antimicrobial resistance helps sustain small-scale agriculture and aquaculture and improve poor people’s access to nourishing food
Particularly in poorer countries already facing a high disease burden, antimicrobial resistance increases the likelihood that medical and veterinary treatments will fail
The problem of antimicrobial resistance can exacerbate gender inequality by increasing the risks faced by female primary caregivers of contracting antimicrobial-resistant infections
Over- and misuse of antibiotics and other antimicrobial drugs can contaminate soil and water resources, endangering people’s access to safe drinking water
It has been estimated that if not stemmed, antimicrobial resistance could cost the global economy up to USD100 trillion by 2050
Rational use of antibiotics and other antimicrobial drugs in good animal and fish husbandry practices is key to safeguarding the longer-term effectiveness of these important drugs
Only large networks of interdisciplinary partnerships and collaborators will be able to meet the many challenges presented by the growing development of antimicrobial resistance